Live Breaking News & Updates on Zydus Wellness Products|Page 5

Stay updated with breaking news from Zydus wellness products. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Zydus Lupin: Lupin, Zydus Lifesciences ink licensing, supply pact for Saroglitazar Mg

Lupin and Zydus Lifesciences entered into a licensing and supply agreement to co-market Saroglitazar Mg, an innovative drug approved by India s DCGI for treating non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Lupin will have semi-exclusive rights to co-market the product in India under the brand name LINVAS. ....

Sharvil Patel , Nilesh Gupta , Zydus Lifesciences Ltd On , Lupin Ltd , Zydus Lifesciences Ltd , Nonalcoholic Steato Hepatitis , Managing Director Nilesh Gupta , Managing Director Sharvil Patel , Zydus Lupin , Saroglitazar Mg ,

Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg

A Critical Treatment for Chronic Liver Diseases in India ....

South Africa , India General , Sujatha Rajesh , Sharvil Patel , Asia Pacific , Nilesh Gupta , Corporate Communications Sustainability , Lupin Limited , Biotechnology Pharmaceuticals , Zydus Lifesciences , Zydus Lifesciences Ltd , Business Wire , Non Alcoholic Fatty Liver Disease , Non Alcoholic Steato Hepatitis , Lifesciences Limited , Diabetes Mellitus , Managing Director , Alcoholic Liver Disease , Non Alcoholic Steatohepatitis , Latin America , Middle East , Great Place , Vice President , Corporate Communications , Hindustan Times , Whatsapp Channels ,

Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg, a Critical Treatment for Chronic Liver Diseases in India

Pti: Zydus and Lupin Sign Licensing Agreement for Co-Marketing Saroglitazar Mg, a Critical Treatment for Chronic Liver Diseases in India ....

Indian Railways , Press Trust Of India ,

Zydus, Lupin enter licensing pact to market drug to treat liver disease

Zydus launched the drug under the brand names Lipaglyn and Bilypsa and will continue to market them. Lupin will pay Zydus upfront licensing fees and milestone payments based on the achievement of pre-defined milestones. With a once-daily, 4mg dose regimen, Saroglitazar Mg enables better compliance, reduces pill burden, and offers greater convenience for patients. ....

Sharvil Patel , Sun Pharma , Zydus Lifesciences , Nilesh Gupta , Non Alcoholic Fatty Liver Disease , Non Alcoholic Steato Hepatitis , Diabetes Mellitus , Market Drug , Treat Liver , Treat Disease , Liver Disease ,

zydus: Zydus bets big on proprietary drugs to boost revenue

Sharvil Patel, managing director of Zydus Lifesciences said, half of the research and development (R&D) allocation is geared towards developing new chemical entities (NCEs), biologics and differentiated products. On average, Zydus spends about 8% of its revenue on R&D, which is higher than the industry average of 6%. ....

Zydus Lifesciences , Sharvil Patel , Sun Pharma , Bets Big , Proprietary Drugs , Boost Revenue , Revenue Growth ,